BXP
49
-3
GS
70
-2
APH
77
2
MTCH
57
2
EW
46
2
XYL
64
2
CAH
69
2
CFG
64
2
UHS
64
-3
ETR
77
6
VRSN
50
-8
NVDA
65
-4
BIIB
48
-3
IPG
31
-2
AXP
67
-3
EQT
48
-2
KMB
51
-2
OKE
52
6
SO
75
7
HIG
66
-2
BXP
49
-3
GS
70
-2
APH
77
2
MTCH
57
2
EW
46
2
XYL
64
2
CAH
69
2
CFG
64
2
UHS
64
-3
ETR
77
6
VRSN
50
-8
NVDA
65
-4
BIIB
48
-3
IPG
31
-2
AXP
67
-3
EQT
48
-2
KMB
51
-2
OKE
52
6
SO
75
7
HIG
66
-2
Financhill
Back

The Bancorp Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
64

TBBK
The Bancorp

Last Price:
$51.10
Seasonality Move:
-2.95%
Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$16.93
Seasonality Move:
0.23%
Buy
64
The Bancorp (TBBK) is a Buy

Is The Bancorp a Buy, Sell or Hold?

  • The current The Bancorp [TBBK] share price is $51.10. The Score for TBBK is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • TBBK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $16.93. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TBBK Stock Price Chart

What is The Bancorp's stock price today?

  • The The Bancorp share price today is $51.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBBK is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $16.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

TBBK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.47 Buy
Relative Strength Index (14 RSI): 47.94 Sell
Chaikin Money Flow: -233950 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.76 - 53.82) Sell
Bollinger Bands (100): (48.3 - 57.86) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 41.45 Sell
Chaikin Money Flow: -1004786 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.86 - 18.96) Sell
Bollinger Bands (100): (18.68 - 28.96) Sell

TBBK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.07 Sell
20-day SMA: 52.62 Sell
50-day SMA: 50.35 Buy
200-day SMA: 53 Sell
8-day EMA: 52 Sell
20-day EMA: 51.84 Sell
50-day EMA: 51.52 Sell
200-day EMA: 50.74 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.4 Sell
20-day SMA: 17.74 Sell
50-day SMA: 19.36 Sell
200-day SMA: 28.18 Sell
8-day EMA: 17.24 Sell
20-day EMA: 17.7 Sell
50-day EMA: 19.64 Sell
200-day EMA: 28.21 Sell

The Bancorp Earnings Growth & TBBK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.21 per share, an increase this year of $0.96 per share, and an increase next year of $1.25 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.

The Bancorp Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):